(Q45245221)

11 December 2017

Naltrexone reduces the relative reinforcing value of nicotine in a cigarette smoking choice paradigm (English)

1 reference

11 December 2017

0 references

0 references

1 reference

7

Caryn Lerman

1 reference

11 December 2017

2

Christopher Jepson

1 reference

11 December 2017

3

Andrew Strasser

1 reference

11 December 2017

Margaret Rukstalis

1

1 reference

11 December 2017

Kevin G Lynch

series ordinal

4

1 reference

11 December 2017

Kenneth Perkins

series ordinal

5

1 reference

11 December 2017

Freda Patterson

series ordinal

6

1 reference

11 December 2017

language of work or name

1 reference

29 January 2005

1 reference

11 December 2017

1 reference

11 December 2017

180

1 reference

11 December 2017

1

1 reference

11 December 2017

41-48

1 reference

https://scigraph.springernature.com/pub.10.1007/s00213-004-2136-8

11 December 2017

0 references

cites work

Preference for high- versus low-potency marijuana.

1 reference

12 December 2020

Nicotine-induced alterations in brain regional concentrations of native and cryptic Met- and Leu-enkephalin.

1 reference

12 December 2020

Efficacy and safety of bupropion SR for smoking cessation: data from clinical trials and five years of postmarketing experience

1 reference

12 December 2020

Effects of naltrexone with nicotine replacement on smoking cue reactivity: preliminary results.

1 reference

12 December 2020

Ethanol self-administration in males with and without an alcoholic first-degree relative.

1 reference

12 December 2020

Naltrexone blockade of nicotine effects in cigarette smokers.

1 reference

12 December 2020

Chronic administration of D-amphetamine increases [3H]spiroperidol binding in cat brain.

1 reference

12 December 2020

Naltrexone alteration of acute smoking response in nicotine-dependent subjects.

1 reference

12 December 2020

Activity of dopamine-containing substantia nigra neurons in freely moving cats.

1 reference

12 December 2020

Nicotine protects against mu-opioid receptor antagonism by beta-funaltrexamine: evidence for nicotine-induced release of endogenous opioids in brain

1 reference

12 December 2020

The metabolism of naltrexone in man

1 reference

12 December 2020

6-beta-naltrexol reduces alcohol consumption in rats.

1 reference

12 December 2020

Bupropion SR for smoking cessation

1 reference

12 December 2020

Individual differences in smoking reward from de-nicotinized cigarettes

1 reference

12 December 2020

Methodological considerations in nicotine research: the use of “denicotinised” cigarettes as the control condition in smoking studies

1 reference

12 December 2020

Nicotine preference in smokers as a function of smoking abstinence.

1 reference

12 December 2020

Forced-choice versus free-choice procedures: caffeine self-administration in humans

1 reference

12 December 2020

Naloxone precipitates nicotine abstinence syndrome in the rat

1 reference

12 December 2020

Naloxone does not affect cigarette smoking

1 reference

12 December 2020

The pharmacotherapy of smoking cessation

1 reference

12 December 2020

The effectiveness of the nicotine patch for smoking cessation. A meta-analysis

1 reference

12 December 2020

The development and initial validation of a questionnaire on smoking urges

1 reference

12 December 2020

Human cigarette smoking: effects of puff and inhalation parameters on smoke exposure

1 reference

12 December 2020

Placebo cigarettes in smoking research

1 reference

12 December 2020

Medications for alcohol, illicit drug, and tobacco dependence. An update of research findings

1 reference

12 December 2020

In vivo characterization of locally applied dopamine uptake inhibitors by striatal microdialysis

1 reference

12 December 2020

The Fagerström Test for Nicotine Dependence: a revision of the Fagerström Tolerance Questionnaire

1 reference

12 December 2020

Pharmacodynamic effects of new de-nicotinized cigarettes.

1 reference

12 December 2020

Naltrexone effects on short-term and long-term smoking cessation

1 reference

12 December 2020

Studies of bupropion's mechanism of antidepressant activity

1 reference

12 December 2020

Nicotine alleviation of nicotine abstinence syndrome is naloxone-reversible

1 reference

12 December 2020

The opioid antagonist naltrexone inhibits activity and alters expression of alpha7 and alpha4beta2 nicotinic receptors in hippocampal neurons: implications for smoking cessation programs

1 reference

12 December 2020

Comparing the reinforcing efficacy of nicotine containing and de-nicotinized cigarettes: a behavioral economic analysis.

1 reference

12 December 2020

Acute doses of d-amphetamine and bupropion increase cigarette smoking

1 reference

12 December 2020

Effect of naloxone on cigarette smoking

1 reference

12 December 2020

Bupropion: a review of its use in the management of smoking cessation

1 reference

12 December 2020

Naloxone challenge in smokers. Preliminary evidence of an opioid component in nicotine dependence

1 reference

12 December 2020

Effect of nicotine on in vivo secretion of melanocorticotropic hormones in the rat

1 reference

12 December 2020

A meta-analysis of the efficacy of over-the-counter nicotine replacement

1 reference

12 December 2020

Duration of occupancy of opiate receptors by naltrexone

1 reference

12 December 2020

Neurochemical and neuropharmacological investigations into the mechanisms of action of bupropion . HCl--a new atypical antidepressant agent

1 reference

12 December 2020

Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administration

1 reference

12 December 2020

Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling

1 reference

12 December 2020

Efficacy of bupropion for smoking cessation in smokers with a former history of major depression or alcoholism

1 reference

12 December 2020

The neurobiology of tobacco dependence: a commentary

1 reference

12 December 2020

Reinforcing effects of nicotine as a function of smoking status

1 reference

12 December 2020

A controlled trial of sustained-release bupropion, a nicotine patch, or both for smoking cessation.

1 reference

12 December 2020

Bupropion for pharmacologic relapse prevention to smoking: predictors of outcome

1 reference

12 December 2020

Dissociating nicotine and nonnicotine components of cigarette smoking.

1 reference

12 December 2020

Estimation of the systemic availability and other pharmacokinetic parameters of naltrexone in man after acute and chronic oral administration

1 reference

12 December 2020

The effect of chronic administration of nicotine on antinociception, opioid receptor binding and met-enkelphalin levels in rats

1 reference

12 December 2020

Naltrexone, smoking behaviour and cigarette withdrawal.

1 reference

12 December 2020

Naltrexone: disposition, metabolism, and effects after acute and chronic dosing

1 reference

12 December 2020

Bupropion: a new antidepressant drug, the mechanism of action of which is not associated with down-regulation of postsynaptic beta-adrenergic, serotonergic (5-HT2), alpha 2-adrenergic, imipramine and dopaminergic receptors in brain.

1 reference

12 December 2020

Bupropion: a review of its mechanism of antidepressant activity.

1 reference

12 December 2020

A comparison of sustained-release bupropion and placebo for smoking cessation

1 reference

12 December 2020

Naltrexone attenuates acute cigarette smoking behavior

1 reference

12 December 2020

The secretory response of hypothalamic beta-endorphin neurons to acute and chronic nicotine treatments and following nicotine withdrawal

1 reference

12 December 2020

Bupropion is a nicotinic antagonist.

1 reference

12 December 2020

Nicotine-induced alteration in Tyr-Gly-Gly and Met-enkephalin in discrete brain nuclei reflects altered enkephalin neuron activity

1 reference

12 December 2020

Acute nicotine reinforcement, but not chronic tolerance, predicts withdrawal and relapse after quitting smoking

1 reference

12 December 2020

Current pharmacological treatments for nicotine dependence

1 reference

12 December 2020

Naloxone reduces cigarette smoking

1 reference

12 December 2020

Effects of smoke deprivation interval on puff topography

1 reference

12 December 2020

10.1007/S00213-004-2136-8

Identifiers

DOI

1 reference

Dimensions Publication ID

11 December 2017

0 references

1 reference